Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gibbons, Daniel C
2482  Ergebnisse:
Personensuche X
?
1

Real-world effectiveness of sotrovimab for the treatment of..:

Drysdale, Myriam ; Berktas, Mehmet ; Gibbons, Daniel C....
Infection.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Real-World Effectiveness of Sotrovimab for the Early Treatm..:

Bell, Christopher F. ; Bobbili, Priyanka ; Desai, Raj...
Clinical Drug Investigation.  44 (2024)  3 - p. 183-198 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Comparative effectiveness of sotrovimab versus no treatment..:

Drysdale, Myriam ; Galimov, Evgeniy R ; Yarwood, Marcus James...
BMJ Open Respiratory Research.  11 (2024)  1 - p. e002238 , 2024
Link: https://doi.org/10.1136/..
 
?
4

Characteristics and outcomes of COVID-19 patients presumed ..:

Patel, Vishal ; Levick, Bethany ; Boult, Stephen...
BMC Infectious Diseases.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

P18 Treatment patterns and extent of inappropriate antimicr..:

Wilcox, Mark ; Heaton, Dave ; Mulgirigama, Aruni...
JAC-Antimicrobial Resistance.  5 (2023)  Supplement_3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
6

510. Real-world Effectiveness of Sotrovimab for COVID-19: E..:

Bell, Christopher F ; Lokhandwala, Tasneem ; Gibbons, Daniel C...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
7

Real-World Effectiveness of Sotrovimab for the Early Treatm..:

Cheng, Mindy M. ; Reyes, Carolina ; Satram, Sacha...
Infectious Diseases and Therapy.  12 (2023)  2 - p. 607-621 , 2023
Link: https://doi.org/10.1007/..
 
?
8

P19 Burden of illness and costs among female patients with ..:

Wilcox, Mark ; Heaton, Dave ; Mulgirigama, Aruni...
JAC-Antimicrobial Resistance.  5 (2023)  Supplement_3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
9

Real-world effectiveness of sotrovimab for the treatment of..:

Drysdale, Myriam ; Gibbons, Daniel C. ; Singh, Moushmi...
Infection.  52 (2023)  1 - p. 1-17 , 2023
Link: https://doi.org/10.1007/..
 
?
10

P17 Baseline characteristics, disease progression rates and..:

Wilcox, Mark ; Heaton, Dave ; Mulgirigama, Aruni...
JAC-Antimicrobial Resistance.  5 (2023)  Supplement_3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

37 Characteristics and outcomes of patients with COVID-19 a..:

Patel, Vishal ; Yarwood, Marcus J. ; Levick, Bethany...
Clinical Infection in Practice.  20 (2023)  - p. 100262 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Prevalent new user designs: A literature review of current ..:

Tazare, John ; Gibbons, Daniel C. ; Bokern, Marleen...
Pharmacoepidemiology and Drug Safety.  32 (2023)  11 - p. 1252-1260 , 2023
Link: https://doi.org/10.1002/..
 
?
13

Treatment patterns, healthcare resource use, and costs asso..:

Moon, Rena C. ; Marijam, Alen ; Mitrani-Gold, Fanny S....
PLOS ONE.  17 (2022)  11 - p. e0277713 , 2022
Link: https://doi.org/10.1371/..
 
?
14

Disease burden of primary biliary cholangitis and associate..:

Gungabissoon, Usha ; Gibbons, Daniel C ; Requena, Gema..
BMJ Open Gastroenterology.  9 (2022)  1 - p. e000857 , 2022
Link: https://doi.org/10.1136/..
 
?
15

1145. Real-world Effectiveness of Sotrovimab for the Early ..:

Cheng, Mindy M ; Gibbons, Daniel C ; Birch, Helen...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
1-15